Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 28, 2015; 21(28): 8588-8604
Published online Jul 28, 2015. doi: 10.3748/wjg.v21.i28.8588
Table 2 Associations between subunit 3 expression in different subcellular localizations in cancerous cells and clinicopathological variables of patients with hepatocellular carcinoma n (%)
FeaturenCCT3 expression in cytoplasm
P valueCCT3 expression in nucleus
P value
(+)(-)(+)(-)
Gender (F/M)
Female2114 (18.7)7 (24.1)11 (19.0)10 (21.7)
Male8361 (81.3)22 (75.9)0.53347 (81.0)36 (78.3)0.726
Age (yr)
< 605639 (52.0)17 (58.6)31 (53.4)25 (54.3)
≥ 604836 (48.0)12 (41.4)0.54427 (46.6)21 (45.7)0.927
Hepatitis type
HBV8559 (78.7)26 (89.7)49 (84.5)36 (78.3)
HCV64 (5.3)2 (6.9)2 (3.4)4 (8.7)
None1312 (16.0)1 (7.7)0.1907 (12.1)6 (13.0)0.581
Cirrhosis
Present7854 (72.0)24 (82.8)43 (74.1)35 (76.1)
None2621 (28.0)5 (17.2)0.25615 (25.9)11 (23.9)0.820
UICC stage
I6446 (61.3)18 (62.1)31 (53.4)33 (71.7)
II1211 (14.7)1 (3.4)0.20810 (17.2)2 (4.3)0.068
IIIA2818 (24.0)10 (34.5)17 (29.3)11 (23.9)
Histological type
Well-differentiated2616 (21.3)10 (34.5)5 (8.6)21 (45.7)
Moderately-differentiated6045 (60.0)15 (51.7)36 (62.1)24 (52.2)
Poorly-differentiated1814 (18.7)4 (13.8)0.37117 (29.3)1 (2.2)< 0.001
Macrovascular invasion
None9971 (94.7)28 (96.6)54 (93.1)45 (97.8)
Present54 (5.3)1 (3.4)1.0004 (6.9)1 (2.2)0.380
Microvascular invasion
None7855 (73.3)23 (79.3)39 (67.2)39 (84.8)
Present2620 (26.7)6 (20.7)0.52819 (32.8)7 (15.2)0.040
Tumor size (cm)
≥ 54635 (46.7)11 (37.9)28 (48.1)18 (62.9)
< 55840 (53.3)18 (62.1)0.42130 (51.9)28 (37.1)0.351
Serum AFP level (ng/mL)
< 4007956 (74.7)23 (79.3)43 (74.1)36 (78.3)
≥ 4002519 (25.3)6 (20.7)0. 61915 (25.9)10 (21.7)0.625
Tumor number
Solitary8362 (82.7)21 (72.4)46 (79.3)37 (80.4)
Multiple2113 (17.3)8 (27.6)0.24312 (20.7)9 (19.6)0.887
Liver encapsulation invasion
None9366 (88.0)27 (93.1)52 (89.7)41 (89.1)
Present119 (12.0)2 (6.9)0.6876 (10.3)5 (10.9)1.000